These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 11699427)

  • 21. Suspect cell convolutes in the bone marrow of a patient with renal cell carcinoma unmasked as atypical convolutes of hairy cells.
    Exner M; Thalhammer-Scherrer R; Kudlacek S; Simonitsch I; Jäger U; Schwarzinger I
    Leuk Lymphoma; 2001 Jun; 42(1-2):239-41. PubMed ID: 11699215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of hair cell leukemia with 2-chlorodeoxyadenosine and G-CSF].
    Bengió R; Pérez M; Sarmiento M; Raña P; Sánchez Lucero A; Sarto A; Arrossagaray G
    Medicina (B Aires); 1996; 56(5 Pt 1):534. PubMed ID: 9239892
    [No Abstract]   [Full Text] [Related]  

  • 23. [Bilateral partial nephrectomy in a case of bilateral synchronous renal cell carcinoma].
    Takemoto J; Suzuki K; Takeuchi M
    Hinyokika Kiyo; 2003 Mar; 49(3):173-5. PubMed ID: 12728534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regression of diffuse osteosclerosis in hairy cell leukaemia after treatment with interferon.
    Verhoef GE; De Wolf-Peeters C; Zachee P; Boogaerts MA
    Br J Haematol; 1990 Sep; 76(1):150-1. PubMed ID: 2223637
    [No Abstract]   [Full Text] [Related]  

  • 25. Hairy cell leukemia with concurrent cryptococcus infection.
    Audeh YM; Gruszecki AC; Cherrington A; Reddy VV
    Am J Hematol; 2003 Mar; 72(3):223-4. PubMed ID: 12605398
    [No Abstract]   [Full Text] [Related]  

  • 26. [Bilateral synchronous renal cell carcinoma: report of three cases].
    Nakatsuji H; Yamashita Y; Karashima T; Hashine K; Sumiyoshi Y
    Hinyokika Kiyo; 1999 Oct; 45(10):695-8. PubMed ID: 10586361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Polyarthritis revealing hairy cell leukemia].
    L'Hirondel JL; Troussard X; Macro M; Courtheoux F; Guaydier-Souquières G; Mandard JC; Loyau G
    Rev Rhum Mal Osteoartic; 1992 Nov; 59(11):749-53. PubMed ID: 1306595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recombinant interferon-alpha 2 antibodies in renal cell carcinoma. Delta-P Study Group.
    Prümmer O; Porzsolt F
    J Interferon Res; 1994 Aug; 14(4):193-5. PubMed ID: 7822873
    [No Abstract]   [Full Text] [Related]  

  • 29. Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer.
    Flanigan RC; Salmon SE; Blumenstein BA; Bearman SI; Roy V; McGrath PC; Caton JR; Munshi N; Crawford ED
    N Engl J Med; 2001 Dec; 345(23):1655-9. PubMed ID: 11759643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of essential thrombocythemia in a patient treated with interferon alfa and pentostatin for hairy cell leukemia.
    Lichtman SM; Wasil T; Ahmad M; Brody J
    Leuk Lymphoma; 1998 Jan; 28(3-4):423-7. PubMed ID: 9517515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Are we really making an advance in the treatment of metastatic renal cell carcinoma?
    Kirkali Z
    Eur Urol; 2006 Apr; 49(4):604-5. PubMed ID: 16481098
    [No Abstract]   [Full Text] [Related]  

  • 32. Granulocyte-macrophage colony-stimulating factor and interferon-alpha 2B in patients with advanced renal cell carcinoma.
    Lümmen G; Sperling H; Luboldt H; Otto T; Rübben H
    Urol Int; 1998; 61(4):215-9. PubMed ID: 10364752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon adjuvant to radical nephrectomy in Robson stages II and III renal cell carcinoma: a multicentric randomized study.
    Pizzocaro G; Piva L; Colavita M; Ferri S; Artusi R; Boracchi P; Parmiani G; Marubini E
    J Clin Oncol; 2001 Jan; 19(2):425-31. PubMed ID: 11208835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interferon alpha 2b as medical selection for nephrectomy in patients with synchronous metastatic renal cell carcinoma: a consecutive study.
    Bex A; Kerst M; Mallo H; Meinhardt W; Horenblas S; de Gast GC
    Eur Urol; 2006 Jan; 49(1):76-81. PubMed ID: 16310929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Successful use of vemurafenib in a patient with resistant hairy cell leukemia].
    Urnova ES; Al'-Radi LS; Kuz'mina LA; Kariakina AA; Kovrigina AM; Dvirnyk VN; Iakutik IA; Sudarikov AB; Parovichnikova EN; Savchenko VG
    Ter Arkh; 2013; 85(7):76-8. PubMed ID: 24137951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prolonged interferon-alpha-2b treatment of hairy cell leukemia patients.
    Bourantas KL; Hatzimichael EC; Makis AC; Kapsali E; Tsiara S; Christou L; Seferiadis K
    Eur J Haematol; 2000 May; 64(5):350-1. PubMed ID: 10863983
    [No Abstract]   [Full Text] [Related]  

  • 37. Hairy cell leukemia: splenectomy after alpha 2b-interferon therapy.
    Pangalis GA; Boussiotis VA; Kittas C; Panayiotidis PG; Loukopoulos D; Fessas P; Mitsoulis-Mentzikoff C
    Blood; 1991 Sep; 78(5):1385. PubMed ID: 1878598
    [No Abstract]   [Full Text] [Related]  

  • 38. Residents' teaching files. Papillary renal cell carcinoma: diagnostic dilemma of a cystic renal mass.
    Roberts SC; Winick AB; Santi MR
    Radiographics; 1997; 17(4):993-8. PubMed ID: 9225396
    [No Abstract]   [Full Text] [Related]  

  • 39. [Renal cell carcinoma discovered in a patient with typical acute pyelonephritis: a case report].
    Makiyama K; Fukuoka H; Kawamoto K; Suwa Y
    Hinyokika Kiyo; 1998 Sep; 44(9):645-7. PubMed ID: 9805669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic immunity-driven polyarthritis in hairy cell leukemia. Report of a case and review of the literature.
    Vernhes JP; Schaeverbeke T; Fach J; Lequen L; Bannwarth B; Dehais J
    Rev Rhum Engl Ed; 1997 Oct; 64(10):578-81. PubMed ID: 9385695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.